Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Cash from Financing Activities (2020 - 2025)

Tarsus Pharmaceuticals has reported Cash from Financing Activities over the past 6 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $2.3 million for Q4 2025, down 21.01% from a year ago — trailing twelve months through Dec 2025 was $143.4 million (down 7.29% YoY), and the annual figure for FY2025 was $143.4 million, down 7.29%.
  • Cash from Financing Activities for Q4 2025 was $2.3 million at Tarsus Pharmaceuticals, down from $2.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TARS hit a ceiling of $136.6 million in Q1 2025 and a floor of -$136000.0 in Q3 2022.
  • Median Cash from Financing Activities over the past 5 years was $2.4 million (2025), compared with a mean of $26.1 million.
  • Peak annual rise in Cash from Financing Activities hit 7473300.0% in 2022, while the deepest fall reached 281.33% in 2022.
  • Tarsus Pharmaceuticals' Cash from Financing Activities stood at -$74000.0 in 2021, then soared by 456.76% to $264000.0 in 2022, then skyrocketed by 7384.85% to $19.8 million in 2023, then tumbled by 85.19% to $2.9 million in 2024, then decreased by 21.01% to $2.3 million in 2025.
  • The last three reported values for Cash from Financing Activities were $2.3 million (Q4 2025), $2.6 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.